Nuwacell Biotech’s NCR101 Approved for ILD Clinical Study by China’s CDE
CompanyDrug

Nuwacell Biotech’s NCR101 Approved for ILD Clinical Study by China’s CDE

Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY
Company

Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY

Horimed Raises USD 13.8M to Advance Optical and Ultrasonic Imaging Tech
CompanyDeals

Horimed Raises USD 13.8M to Advance Optical and Ultrasonic Imaging Tech

Gene Cradle and Byongen Therapeutics Partner on Next-Generation DMD Gene Therapies
CompanyDeals

Gene Cradle and Byongen Therapeutics Partner on Next-Generation DMD Gene Therapies

Bristol-Myers Squibb's Opdivo Shows Survival Benefit in CheckMate-816 Study
CompanyDrug

Bristol-Myers Squibb’s Opdivo Shows Survival Benefit in CheckMate-816 Study

Corxel Pharmaceuticals to Test JX10 in Acute Ischemic Stroke Patients with NMPA Approval
CompanyDrug

Corxel Pharmaceuticals to Test JX10 in Acute Ischemic Stroke Patients with NMPA Approval

Harbour BioMed and Insilico Medicine Partner on AI-Powered Antibody Development
CompanyDeals

Harbour BioMed and Insilico Medicine Partner on AI-Powered Antibody Development

Gilead's Livdelzi Receives Conditional EC Approval for Primary Biliary Cholangitis
CompanyDrug

Gilead’s Livdelzi Receives Conditional EC Approval for Primary Biliary Cholangitis

FibroGen to Sell China Subsidiary to AstraZeneca for ~$160M, Roxadustat Rights Included
CompanyDeals

FibroGen to Sell China Subsidiary to AstraZeneca for ~$160M, Roxadustat Rights Included

Waterdrop Integrates DeepSeek AI to Boost Insurance Ecosystem
CompanyDeals

Waterdrop Integrates DeepSeek AI to Boost Insurance Ecosystem

Boehringer Ingelheim Launches LENTICLAIR Study for CF Gene Therapy BI 3720931
CompanyDrug

Boehringer Ingelheim Launches LENTICLAIR Study for CF Gene Therapy BI 3720931

Huadong Medicine's Biosimilar Tresiba Accepted by NMPA for Review
CompanyDrug

Huadong Medicine’s Biosimilar Tresiba Accepted by NMPA for Review